jurnal ttrial sce3

Upload: danita-dwityana-gamalwan

Post on 03-Jun-2018

227 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/12/2019 jurnal ttrial sce3

    1/7

    Vitamin C And Vitamin ESupplementation In Pregnant WomenAt Risk For Pre Eclampsia : ARandomized Controlled Trial.

    AstractEvidence suggests that antioxidant supplementation reduces risk of preeclampsia. Our aim

    was to investigate the potential benefit of antioxidants in women with risk factors of

    preeclampsia. A total of 285women identified at risk of preeclampsia were administered

    vitamin C !!! mg" vitamin E 2!!mg # placebo from 2 weeks of pregnanc$ till deliver$ in

    intention to treat. %he patients were randoml$ assigned to drug groups. %he &ncidence of

    preeclampsia" intrauterine growth retardation" and caesarean between placebo and vitamin

    group were compared and were found to be same. 'ut preterm birth reduced in statisticall$

    significant number in vitamin group (O) * !.28" C& * !.2 + !.,," p * !.!-.

    Introductionre+eclampsia is a multis$stem disorder characteri/ed b$ h$pertension and roteinuria

    occurring in second half of the pregnanc$. %his condition is best described as a pregnanc$

    specific s$ndrome of reduced organ perfusion secondar$ to vasospasm and endothelial

    activation.%he exact incidence of pre+eclampsia is unknown" but about 50 pregnant

    women develop pregnanc$ induced h$pertension. Out of this 150 will have one maor

    complication.2" Eclampsia is responsible for nearl$ 20 of all maternal mortalities in

    world2and .80 mortalit$ in 34. As per ational 6amil$ 7ealth urve$ 2!!5+2!!9

    &nternational institute of population ciences :umbai (2!!;-" !.10 women will have

    convulsions. 'ecause of the seriousness of the condition studies to find means of

    preventing and treating pre+eclampsia are ver$ important. 7$pertension along with

    hemorrhage and sepsis forms the deadl$ triad responsible for maorit$ of maternal deaths.

    %here is increasing evidence that pre+eclampsia is associated with both increased oxidative

    stress and reduced antioxidants defenses. Circulating levels of oxidative stress markers

    have been found to be elevated and that of antioxidants depressed in women with pre+

  • 8/12/2019 jurnal ttrial sce3

    2/7

    eclampsia compared to women without the disorder.1" these observations on the effects of

    oxidative stress in pre+eclampsia have given rise to increase interest in the potential

    benefits of antioxidant therap$ given for the prevention of h$pertensive disorders of

    pregnanc$. Antioxidants are a diverse famil$ of components that function to prevent

    overproduction of and damage caused b$ noxious free radicals. Examples of antioxidantsinclude

  • 8/12/2019 jurnal ttrial sce3

    3/7

    re+eclampsia is associated with both increased oxidative stress and reduced antioxidants

    defenses. Circulating levels of oxidative stress markers have been found to be elevated and

    that of antioxidants depressed in women with pre+eclampsia compared to women without

    the disorder. %hese observations on the effects of oxidative stress in pre+eclampsia have

    given rise to increase interest in the potential benefits of antioxidant therap$ given for theprevention of h$pertensive disorders of pregnanc$. Antioxidants are a diverse famil$ of

    components that function to prevent overproduction of and damage caused b$ noxious free

    radicals. %his stud$ is designed to test the h$pothesis that treatment of pregnant women

    with antioxidants would alter endothelial cell inur$ linked to preeclampsia reducing the

    incidence of h$pertensive disorder during pregnanc$.

    'et&ods

    %he stud$ was conducted in the Bepartment of Obstetrics and $necolog$ of overnment

    :edical College 7ospital" Chandigarh. %he present stud$ was prospective randomi/ed

    control interventional trial conducted during the period extending from Dune 2!!9 to August

    2!!;. A total of 285 primigravida attending antenatal clinic were enrolled#registered. %he

    group &A was administered orall$ vitamin+C !!!mg and vitamin+E 2!!mg and was labeled

    as intervention group (

  • 8/12/2019 jurnal ttrial sce3

    4/7

    A&B (on steroidal anti+inflammator$ drug-. tatistical anal$sis was done b$ using

    ormal test of proportions" Chi sFuare+test" Odds ratios along with ,50 confidence interval.

    +2 software was used for conducting statistical anal$sis.

    ResultsAt the outset with the aim of substantiating whether primi are at higher risk for various

    complications like preeclampsia" preterm labor" &3)" ?C etc." their incidence in primi

    was compared with multi+gravida mother without an$ intervention in either group. %here

    were = cases of eclampsia out of total of !! multi gravida in contrast to cases in

    primigravida (group &'-. ince among multi+gravida (group+&&- pre+eclampsia" as compared

    to primi+gravida (group+&'- was significantl$ less even without intervention" this group && +

    was excluded from further anal$sis. Out of =! primigravida registered as group &'" 8 were

    lost to follow up and 9 delivered outside. %hus final anal$sis was for !, subects. Out of

    total =5 primi+gravida registered and intended for intervention (&A group-" 9 lost to follow

    up and 22 delivered outside. 7ence final anal$sis for !; subects was done. %he patients

    of placebo and vitamin group were well matched economicall$ and educationall$" compared

    to placebo group" vitamin group has less pre+eclampsia disorder but it was not statisticall$

    significant (O) * !.==" p * !.2-. 7owever a chance association finding of reduced rate of

    preterm birth (birth weight G 2.5 kg- was observed in supplemented group (O) * !.28" C& *

    !.2 to !.,," p * !.!- which is statisticall$ significant. rowth retarded babies did not show

    an$ statisticall$ significant reduction in supplemented group as compared to placebo group

    (O) * !.,1" C& * !.18+2.1 " p * !.82" H2 * !.!1-.

  • 8/12/2019 jurnal ttrial sce3

    5/7

    (Tale)*+ C!'PARISI!, !F C!'P-ICATI!,S !F PRE)EC-A'PSIA I, TW! R!/PS

    0iscussion

    %he overall incidence of pre+eclampsia was ;.!=0 which is in agreement with ;.90incidence observed b$ 7auth et al., Observing no significant difference in the incidence of

    pre+eclampsia between vitamin and placebo group b$ present stud$ is in agreement with

    other authors.5"" 9 %he latter group used same doses of

  • 8/12/2019 jurnal ttrial sce3

    6/7

    support our results. &nterpretation of the results + taking into account our stud$ h$potheses

    antioxidant did not lead to reduction in the rate of pre eclampsia in women" but can reduce

    the rate of preterm deliveries.

    Conclusion%he supplementation of vitamin E and vitamin C to pregnant women at risk of preeclampsia

    did not alter the rate of development of preeclampsia" intrauterine growth retardation or the

    rate of caesarean sections in this stud$.

  • 8/12/2019 jurnal ttrial sce3

    7/7

    5. icolaos . ol$/os" Bavide :auri" :aria %sappi et al. Combined vitamin C and E

    supplementation during pregnanc$ for preeclampsia prevention A s$stematic review.

    Obstetrical and $necological urve$ 2!!;I92(1-2!2+2!9.

    9. oston ?" 'rile$ A?" eed %" 4ell$ 6D et al.